BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 15345309)

  • 21. Secretory IgA induces antigen-independent eosinophil survival and cytokine production without inducing effector functions.
    Bartemes KR; Cooper KM; Drain KL; Kita H
    J Allergy Clin Immunol; 2005 Oct; 116(4):827-35. PubMed ID: 16210057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new, one-step assay on whole cell suspensions for peroxidase secretion by human neutrophils and eosinophils.
    Menegazzi R; Zabucchi G; Knowles A; Cramer R; Patriarca P
    J Leukoc Biol; 1992 Dec; 52(6):619-24. PubMed ID: 1334501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating eosinophils in asthma, allergic rhinitis, and atopic dermatitis lack morphological signs of degranulation.
    Malm-Erjefält M; Greiff L; Ankerst J; Andersson M; Wallengren J; Cardell LO; Rak S; Persson CG; Erjefält JS
    Clin Exp Allergy; 2005 Oct; 35(10):1334-40. PubMed ID: 16238793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A kinetic assay for eosinophil peroxidase activity in eosinophils and eosinophil conditioned media.
    White SR; Kulp GV; Spaethe SM; Van Alstyne E; Leff AR
    J Immunol Methods; 1991 Nov; 144(2):257-63. PubMed ID: 1660059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of specific IgE antibodies in peroxidase (EPO) release from human eosinophils.
    Khalife J; Capron M; Cesbron JY; Tai PC; Taelman H; Prin L; Capron A
    J Immunol; 1986 Sep; 137(5):1659-64. PubMed ID: 3489038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myeloperoxidase is more efficient than eosinophil peroxidase in the in vitro killing of newborn larvae of Trichinella spiralis.
    Buys J; Wever R; Ruitenberg EJ
    Immunology; 1984 Mar; 51(3):601-7. PubMed ID: 6321330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Taurine chloramine inhibits functional responses of human eosinophils in vitro.
    Martinez-Losa M; Cortijo J; Piqueras L; Sanz MJ; Morcillo EJ
    Clin Exp Allergy; 2009 Apr; 39(4):537-46. PubMed ID: 19222497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [EPO release from eosinophils].
    Hirai K
    Nihon Rinsho; 1997 Mar; 55 Suppl 1():219-21. PubMed ID: 9097593
    [No Abstract]   [Full Text] [Related]  

  • 29. Interferon-gamma enhances human eosinophil effector functions induced by granulocyte-macrophage colony-stimulating factor or interleukin-5.
    Yamaguchi T; Kimura H; Kurabayashi M; Kozawa K; Kato M
    Immunol Lett; 2008 Jun; 118(1):88-95. PubMed ID: 18440651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of enantiomeric forms of albuterol on stimulated secretion of granular protein from human eosinophils.
    Leff AR; Herrnreiter A; Naclerio RM; Baroody FM; Handley DA; Muñoz NM
    Pulm Pharmacol Ther; 1997; 10(2):97-104. PubMed ID: 9425641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of myeloperoxidase and nitrotyrosine formation in a human eosinophilic leukemia cell line, EoL-1.
    Kodama N; Kambayashi Y; Kubo M; Nobukuni Y; Kimura S; Nakamura H; Ogino K
    Cell Biochem Funct; 2004; 22(2):105-12. PubMed ID: 15027099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Virucidal effect of stimulated eosinophils on human immunodeficiency virus type 1.
    Klebanoff SJ; Coombs RW
    AIDS Res Hum Retroviruses; 1996 Jan; 12(1):25-9. PubMed ID: 8825615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of the very late adhesion molecule 4 antagonist WAY103 on human peripheral blood eosinophil vascular cell adhesion molecule 1-dependent functions.
    Sedgwick JB; Jansen KJ; Kennedy JD; Kita H; Busse WW
    J Allergy Clin Immunol; 2005 Oct; 116(4):812-9. PubMed ID: 16210055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interactions of eosinophil granule proteins with skin: limits of detection, persistence, and vasopermeabilization.
    Davis MD; Plager DA; George TJ; Weiss EA; Gleich GJ; Leiferman KM
    J Allergy Clin Immunol; 2003 Nov; 112(5):988-94. PubMed ID: 14610493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The potential role of nitric oxide in substrate switching in eosinophil peroxidase.
    Galijasevic S; Proteasa G; Abdulhamid I; Abu-Soud HM
    Biochemistry; 2007 Jan; 46(2):406-15. PubMed ID: 17209551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Arming of mononuclear phagocytes by eosinophil peroxidase bound to Staphylococcus aureus.
    Ramsey PG; Martin T; Chi E; Klebanoff SJ
    J Immunol; 1982 Jan; 128(1):415-20. PubMed ID: 7054281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum eosinophil granule proteins predict asthma risk in allergic rhinitis.
    Nielsen LP; Peterson CG; Dahl R
    Allergy; 2009 May; 64(5):733-7. PubMed ID: 19133919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extracellular release of peroxidase from eosinophils by interaction with immune complexes.
    Takenaka T; Okuda M; Kawabori S; Kubo K
    Clin Exp Immunol; 1977 Apr; 28(1):56-60. PubMed ID: 301076
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Responsiveness of eosinophils to aeroallergens may be independent of atopic status.
    Redvall E; Bengtsson U; Wennerås C
    Scand J Immunol; 2008 Apr; 67(4):377-84. PubMed ID: 18282233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD28 and secretory immunoglobulin A-dependent activation of eosinophils: inhibition of mediator release by the anti-allergic drug, suplatast tosilate.
    Woerly G; Decot V; Loiseau S; Loyens M; Chihara J; Ono N; Capron M
    Clin Exp Allergy; 2004 Sep; 34(9):1379-87. PubMed ID: 15347370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.